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Abstract
Background: Epidemiological evidence indicates that atopic asthma correlates with high serum IgE levels though the
contribution of allergen specific IgE to the pathogenesis and the severity of the disease is still unclear.
Methods: We developed a microarray immunoassay containing 103 allergens to study the IgE reactivity profiles of 485
asthmatic and 342 non-asthmatic individuals belonging to families whose members have a documented history of asthma
and atopy. We employed k-means clustering, to investigate whether a particular IgE reactivity profile correlated with asthma
and other atopic conditions such as rhinitis, conjunctivitis and eczema.
Results: Both case-control and parent-to-siblings analyses demonstrated that while the presence of specific IgE against
individual allergens correlated poorly with pathological conditions, particular reactivity profiles were significantly associated
with asthma (p,10E-09). An artificial neural network (ANN)-based algorithm, calibrated with the profile reactivity data,
correctly classified as asthmatic or non-asthmatic 78% of the individual examined. Multivariate statistical analysis
demonstrated that the familiar relationships of the study population did not affect the observed correlations.
Conclusions: These findings indicate that asthma is a higher-order phenomenon related to patterns of IgE reactivity rather
than to single antibody reactions. This notion sheds new light on the pathogenesis of the disease and can be readily
employed to distinguish asthmatic and non-asthmatic individuals on the basis of their serum reactivity profile.
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Introduction
Asthma is one of the most common diseases affecting both
adults and children and accounts for up to 300 million [1] cases
worldwide. Worryingly, its frequency has increased annually
during the last five decades [2,3]. Both genetic (cytokines and
immune response genes) [4,5], developmental and environmental
factors (viral infections [6], allergens [7] and occupational
exposures [8] have been associated with asthma susceptibility,
age of onset and severity. Although the pathogenesis of the disease
has not been fully elucidated yet, a major risk factor is the
development of immune responses to foreign antigens, that are
characterized by the production of antigen-specific IgE [9]. This
notion has been first inferred from observations showing that the
prevalence of asthma was closely related to the serum IgE level
standardized for age and sex [10]. Overwhelming evidence has
confirmed the role of IgE in atopic asthma, while several studies
have also revealed a link between IgE and non-atopic asthma [11].
More controversial is the role of antigen specific IgE in
determining the onset and severity of the disease. Several studies
have unraveled strong relationships among exposure to house dust
mite (HDM), the presence of serum IgE directed against the mite
allergens, and asthma [12]. However, a large number of
individuals worldwide, particularly those living in some regions
of USA and Scandinavia, have low lifetime exposure to mite
antigens, but do not show any decrease in the prevalence and the
severity of asthma [13]. Therefore, other antigens -either alone or
in combination- ought to have the ability to elicit an IgE response
and play a role in the pathogenesis of the disease. Indeed the links
among antigen exposure, IgE production, and occurrence and/or
severity of asthma seem to involve an unexpected number of
factors, and a nonlinear relationship between exposure and
response appears to exist [14]. To date, studies of the association
between specific IgE and asthma have focused on analyzing either
one or a few antigens at a time, like for example those describing
the role of HDM [15–18]. The disproportion between the
repertoire of known allergens and the number of antigens that
have been analyzed may well explain the difficulties encountered
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in establishing the role of specific IgE in the pathogenesis of
asthma.
We generated a microarray containing a vast repertoire of
allergens (103) that forms the substrate of an antibody-capture
assay to investigate the IgE reactivity profiles of 872 individuals
belonging to families with documented history and diagnosis of
asthma and atopic diseases. Then, we searched for associations
between IgE reactivity profiles and atopic diseases including
asthma, rhinitis, conjunctivitis and eczema in a case-control and
parent-to-siblings study. Multivariate analysis was carried out to
assess the effect of family relationships on the statistical analysis.
The results of the IgE reactivity profiles were utilized to develop
and validate an artificial neuronal network classifier capable of
distinguishing asthmatic and non-asthmatic individuals with high
accuracy.
Materials and Methods
Population case study
The sample consisted of a total of 872 sera, including 442
parents and their progeny (430 individuals) (Table 1). Within the
study group, 428 children and 57 parents (55.62% of the total)
were diagnosed with asthma, 342 parents (39.22% of the total)
were classified as non asthmatic, though some of them suffered
from atopy related disorders such as rhinitis, conjunctivitis and
eczema, a remaining 5.16% were classified as undefined asthma
diagnosis. Atopic asthmatic sibling pairs (sibs) and trios were
collected over a period of 4 years, mainly from pediatric and
pneumological centers. All patients were of Sardinian origin for at
least 3 generations and their age at visit was above 6 years to avoid
subjects with transient symptoms. At the recruitment sessions, each
subject was interviewed, disease status ascertained by physical
examination, permission asked to access personal health records,
and blood samples were collected. Each participant signed an
informed consent form approved by the local ethics committee
(Azienda Sanitaria Locale number 8 protocol 24/Comitato Etico/
02, authorization number 4737). Asthma was diagnosed by a
pulmonary physician, in accordance with the American Thoracic
Society criteria [19]. Pulmonary function was evaluated by
spirometry. A physician administered a questionnaire collecting
clinical history and classifying asthma severity in four levels
according to the World Health Organization guidelines (Global
Initiative for Asthma). The use of asthma drugs and any other
medication was recorded. Atopy was detected by positive skin
testing to common inhalant allergens by standard methods.
Patients with history of early asthma onset were interviewed by
a physician about persistency of asthma symptoms after the
completion of puberty (18 years).
Development of IgE microarray immunoassay
The serum IgE reactivity was analyzed using a fluorescence
immunoassay that incorporates as a substratum a microarray of
103 allergens (Table S1) including 95 extracts and 8 recombinant
proteins representative of 11 distinct allergen classes chosen
amongst those most frequently associated with atopic diseases in
Southern-Central Europe. Comparisons performed between the
ELISA and the microarray assay for 6 common allergens, revealed
that the overall diagnostic performance, as defined by clinical
sensitivity and specificity, of the microarray immunoassay was very
good [20]. To generate the array the allergens were printed onto
aldehyde-activated glass microscope slides in duplicates at
randomised positions in the array. The immunoassay procedure
consisted of four phases (printing, processing, scanning, quantification and
analysis). Two chips of 103 allergens each, were printed onto each
slide using high–speed robotics (Microgrid Compact; Biorobotics).
Allergens (Allergopharma) were spotted onto the arrays in the
following spotting buffers: PBS pH 7.4, glycine pH 2.4, Borate
pH 9.4, glycerol 10%, DTT 5 mM, SDS (0.2%; 0.05%), Tween
20 (0.01%) at a spotting concentration ranging from 0.008 to
3 mg/ml. Bound IgE were revealed incubating the slides first with
serum sample (100 ml- 60 minutes at 37uC), followed by a
secondary mouse monoclonal antibody directed against human
IgE (100 ml- 45 minutes at 37uC), followed by anti-mouse IgG
Table 1. The population study samples.
Offspring Parents
Parent and
offspring
(N=430) (N=442) (N=872)
Age
Minimum 6.00 25.00 6.00
Maximum 65.80 88.60 88.60
Mean (S.D.) 21.31 (12.02) 47.05 (10.47) 34.30 (17.10)
Median 20.00 46.00 36.00
Sex
Male (%) 245 (56.97*) 201 (45.47) 446 (51.15)
Female (%) 185 (43.03) 241 (54.53) 426 (48.85)
Rhinitis
Affected (%) 324 (75.35) 104 (23.53) 428 (49.08)
Not affected (%) 92 (21.39) 310 (70.14) 402 (46.10)
Undefined diagnosis (%) 14 (3.26) 28 (6.33) 42 (4.82)
Eczema
Affected (%) 132 (30.70) 40 (9.05) 172 (19.72)
Not affected (%) 281 (65.35) 365 (82.58) 646 (74.08)
Undefined diagnosis (%) 17 (3.95) 37 (8.37) 54 (6.20)
Conjuntivitis
Affected (%) 191 (44.42) 74 (16.74) 265 (30.39)
Not affected (%) 201 (46.74) 302 (68.33) 503 (57.68)
Undefined diagnosis (%) 38 (8.83) 66 (14.93) 104 (11.93)
Asthma
Affected (%) 428 (99.50) 57 (12.90) 485 (55.62)
Not affected (%) 0 342 (77.37) 342 (39.22)
Undefined diagnosis (%) 2 (0.50) 43 (9.73) 45 (5.16)
Age of asthma onset
Minimum 1.00 - -
Maximum 57.00 - -
Mean (S.D.) 10.35 (10.82) - -
Asthma severity
1u level (%) 115 (26.74) - -
2u level (%) 76 (17.67) - -
3u level (%) 75 (17.44) - -
4u level (%) 132 (30.69) - -
Undefined diagnosis (%) 32 (7.44) - -
Asthma persistency*
Persistent (%) 290 (67.44) - -
Not persistent (%) 35 (8.14) - -
Undefined diagnosis (%) 105 (24.42) - -
*Persistency of asthma symptoms after the age of 18.
doi:10.1371/journal.pone.0022319.t001
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HRP conjugated antibody (100 ml- 45 minutes at 37uC) and finally
incubated with tyramide-Alexa 555 (100 ml- 15 minutes at 37uC).
The ScanArrayTM software provided by Perkin Elmer Life
Sciences Inc. was used to scan the slides and to acquire the
fluorescence. After subtracting the background signal the concen-
trations (IU/ml) of allergen-bound IgE were determined by
interpolating the signal with an internal calibration curve printed
onto each microarray. To assign IU/ml values to the calibration
curve, we used an external Reference Curve generated by
microarray slides printed with replicates of Goat anti-Human
IgE and incubated with increasing concentrations of human IgE
(WHO Reference standard 0.35, 1.0, 3.5, 10.0, 50.0 IU/ml). The
signal collected from the allergens was interpolated with the
calibration curve to obtain the IU/ml value, and translated into a
Class Score by plotting the data in a standard reactivity scale.
Class Score values: (CLASS 0 (less than 0.35 IU/ml); CLASS 1
(0.35–0.7 IU/ml); CLASS 2 (0.71–3.5 IU/ml); CLASS 3 (3.51–
17.5 IU/ml); CLASS 4 (17.51–50 IU/ml); CLASS 5 (50.01–
100 IU/ml).
The microarray data has been submitted to Gene Expression
Omnibus - GEO-NCBI, accession numbers GSE20020; Platform
GPL9968 ‘‘Allergochip for asthma diagnosis’’
A detailed description of the array procedure is described in the
supporting information (Text S1).
Statistical analysis
Reactivity data from each serum were quantified in IU/ml,
transformed into class score and encoded with 103-dimensional
vectors (1 dimension for each allergen) using Cluster 3.0 [21] to
generate individual profiles. We used k-means clustering to group
sera into distinct clusters on the basis of similarities in their
reactivity profiles, while MapleTree [22] was used for visualizing the
clustering results. Clustering is a statistical technique for collecting
objects into a fixed number of groups (clusters) so that each group
contains only similar objects. In this work we used k-means
clustering, a clustering technique where the target number of
clusters (k) is user-defined. In clustering, similarity is determined by
attributes associated to each object. In this case, each object is a
serum, and its attributes are the reactivity data derived from 103
allergens; k-means clustering was therefore aimed at grouping 872
sera into k clusters, so that each cluster would contain only sera
with similar reactivity data (derived from their 103 allergens). To
assess whether two objects (sera) are similar, which is needed to
collect them in the same cluster, their attributes (103 allergen
reactivity values) must be compared: this is achieved by defining a
similarity metric, i.e. a mathematical formula that combines attribute
values of two objects into a meaningful measure of their similarity.
In this work, Euclidean distance was adopted as similarity metric, i.e.
the square root of the sum of the squared differences of each
attribute. The smaller the Euclidean distance, the more similar the
two objects. The k-means clustering algorithm works by iteratively
inserting each object (serum) into a tentative cluster, and by
refining the insertion process until the similarity of the objects
within each cluster is maximised. In this case, convergence to an
optimal solution was achieved within 10,000 iterations of the
clustering algorithm. The disadvantage of k-means clustering is
that the number of clusters (k) is user defined. Therefore, to
determine what value of k would produce optimal results, we first
ran multiple clustering analyses with different k values (from 1 to
14 and 20) and then we analysed the clustering results using
indicators that measure how similar the objects are within each
cluster, and how different the clusters are with each other. We
used five performance indicators (Silhouette index, Dunn index,
Davies Bouldin, C-index and Isolation index), as provided by the
Machaon software [23], to validate the statistical significance of
each partitioning attempt; we determined that K= 3 was the most
significant result overall.
Then, we proceeded to determine whether the clustering results
would contain significant information also concerning associations
with age, sex, and the presence of a pathological condition
(asthma, rhinitis, etc.), its persistency and/or severity, age at onset,
etc. Statistical tests such as Pearson’s x2 and Kruskall-Wallis non-
parametric test were run within the SPSS software and Excel to
investigate whether the frequency of a pathological condition
differed significantly in the clusters and whether each cluster
significantly differed from the study population taken as a whole.
In particular, the x2 test was used for analysing binary attributes
(i.e. asthmatic vs. non-asthmatic), while the Kruskall-Wallis test
was performed on discrete numeric variables (such as the age of
asthma onset).
Artificial neural network asthma classifier
An artificial neural network (ANN), known as the radial basis
function (RBF) [24] was adopted to implement the asthma classifier.
Professional software applications, which have modules specifically
dedicated for ANN, such as the RBF (Radial Basis Function
Algorithm - SPSS 17.0.) were utilized for developing the classifier.
The neural network analysis was accomplished by using as input
data, a sample data set that includes 51 allergens and the sera
reactivity profiles of 827 individuals. Within the sample, 485 are
asthma positive individuals, and 342 negative. To evaluate the
actual improvement that was achieved by reducing the number of
allergens to be considered by the classifier (by means of the Mann-
Whitney test, as illustrated previously), a separate RBF was trained
on the complete set of allergens, and then its results compared with
the RBF operating on the filtered set. The sample was first
randomized and the size of the training sample used was about
60% of the entire population, while the remaining individuals
were left for validation purposes (testing 10% and holdout of 30%).
The training subset was selected using randomization criterion
that ensures the representativeness of the sample with respect to
the entire population. This is to ensure that the RBF replicates a
behaviour that is representative for the whole population. The
whole supervised training process was repeated 10 times, each
time on a new, previously untrained network, and each time with a
new randomized subset of the original population. This is to
observe any variation in performance, which may be linked to
variability in the representativeness of the training sample. There
are three layers in the RBF network (Input, RBF and output layer).
There are many types of radial basis functions; we used the
Normalized RBF (NRBF). To have an estimate of the real
efficiency of the neural network, the neural network has been run
10 different times. And the overall efficiency of the Network is
given as the mean of the 10 different trials.
Generalized Estimating Equations (GEE) analysis
The results were processed with Generalized Estimating
Equations (GEEs) [25] to test for associations between asthma
and IgE reactivity taking into account for familiar relationships
between asthmatic and non-asthmatic individuals. GEEs are a
semi-parametric regression technique useful for fitting the
parameters of a model where unknown correlation between
variables may be present. The GEE probit analysis is similar to
probit regression models (appropriate for dichotomous dependent
variable and a set of explanatory variables), but it also takes into
account relationships amongst members of the same cluster, in this
case parent to sibling relationships. In this study, a ‘‘working’’
correlation matrix for the clusters, which models the dependence
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of each observation with other observations in the same cluster,
was specified. The familial correlation was modelled assuming
exchangeable correlation for the working correlation matrix, i.e.
all measurements on the same cluster are equally correlated.
Regardless of the specification of the correlation, GEE models are
robust to the misspecification of the correlations structure.
Additionally, we selected robust standard errors (sandwich
estimators as opposed to conventional standard errors) that
allowed the estimates to be valid even in the event of
misspecification of the correlation structure.
The association between asthma and specific IgE against single
allergens was first studied by GEE univariate analyses, determin-
ing possible significant explanatory variables to be included in the
model runs. Multicollinearity among potential explanatory
variables was investigated using regression diagnostic capabilities
to ensure no model-burdening correlations exist between variables.
In these analyses specific IgE against single allergens were
regarded as factors with 4 levels, since class scores 5 having low
frequencies were unified to class score 4. Finally, in order to
identify variables predisposing independently to asthma, we
performed a multivariate logistic regression model for those
variables found from the univariate analysis to have P,0.05, using
a forward modelling strategy and the corresponding odds ratio,
confidence interval and statistical significance were calculated for
each class score of specific IgE in the model. Age, gender and the
interaction between these variables were included as covariates.
The GEE was run in SPSS v16.0.
Results
We have investigated the IgE serum reactivity of 872 individuals
belonging to 283 Sardinian families in which all the progeny (1 to
3 siblings) was affected by atopic asthma (Table 1). The individuals
enrolled in this study included the two parents and their siblings,
mostly children below the age of 27 (75%). The rationale of using
this particular cohort originates from the notion that asthma has
both genetic and environmental components that are not well
defined yet. A sample study comprised of families (parents-
children) from a genetically isolated population like the Sardinians
offers a unique opportunity to minimize possible sources of genetic
heterogeneity and to reduce difference in allergen exposure. The
immunoassay was calibrated (using an internal standard curve) to
measure the amount of specific IgE binding to each of the arrayed
antigens (Table S1) ranging from 0.35 IU/ml to 100 UI/ml. The
reactivity values in UI/ml were converted into class scores using a
validated 0–5 scale [20]. This approach generated 872 distinct IgE
reactivity profiles and an excess of 90,000 antibody-antigen
determinations. A color-coded digital profile (from black to
increasing intensity of red) matching the IgE class score (0 to 5)
against the arrayed allergens was generated for each serum
(Figure 1).
We employed k-means clustering [26], a partitioning method
commonly used to identify group structure within microarray data
to investigate the structure of the reactivity profiles. A significant
amount of literature work addresses clustering as a valid statistical
method to study asthma [15]. The clustering algorithm was run
with different values of k (from 3 to 14 and 20) to split the profiles
into different groups. Statistical analysis computed with Machaon
software [22], showed that k=3 is the partition value that, by
arranging the profiles into three clusters, maximizes intra cluster
similarities and inter cluster differences (Table S2). To validate the
capability of the clustering analysis to separate asthmatic and non-
asthmatic reactivity profiles, we assessed the frequency of
asthmatic and non-asthmatic individuals in the three clusters in
a sample consisting of 114 individuals chosen amongst the parents
equally divided between asthmatic (cases) and non-asthmatic
(controls) individuals. Furthermore, cases and controls were
selected so that matched pairs could be formed in terms of age
and sex (Table S3). This analysis showed that the distribution of
cases and controls significantly differed in two out of three clusters.
While cluster 2 did not show differences in the number of cases
and controls, both cluster 0 and 1 were enriched with non-
asthmatic and asthmatic individuals respectively (p,0.01 in the
Pearson’s x2) thus indicating that cases and controls had distinct
reactivity profiles against the arrayed allergens (Table S4). We
investigated how members of the entire 283 parent-siblings cohort
pairs were distributed in cluster 0, 1 and 2 stratified according to
the presence of atopic diseases such asthma, conjunctivitis,
eczema, rhinitis and other traits (age, sex, disease persistency
and severity). This analysis indicated that the three clusters were
significantly different in terms of frequency of asthma (p = 2.95E-
12), conjunctivitis (p = 6.81E-10), eczema (p = 1.10E-03), rhinitis
(p = 2.35E-07) and sex (Table 2). In agreement with the case-
control analysis, cluster 1 showed an impressively higher
proportion of asthmatic individuals (83%), if compared to the
other two clusters (Figure 1A), and also with respect to the entire
study sample (x2 = 33.480, p= 7.19E-09) (Figure 1B). Similarly
significant associations could also be observed for conjunctivitis
and rhinitis with cluster 1. The partitioning of the profiles
highlighted also an unequal distribution of the familiar nuclei
(Table S5). While cluster 1 contained a significantly high
proportion of affected children, but very few parents, clusters 0
and 2 were enriched for members of the same families and showed
a similar percentage of asthmatic and non-asthmatic individuals.
We reasoned that family members segregating in these two clusters
showed a similar IgE recognition profile irrespectively of asthma,
possibly because of the common exposure to particular sets of the
arrayed allergens. The array was designed without a detailed
knowledge of the exposure to allergens of the study population and
without any a priori assumption on the role of particular allergens
in eliciting an IgE response associated with asthma. It is therefore
not surprising that some allergens are rarely recognized while
others show similar percentages of reactivity in asthmatic and non-
asthmatic individuals. The reactivity against these allergens
contributes to the formation of the profile and could represent a
source of ‘‘background noise’’ that masks relevant associations
with the asthma status. To address this problem we attempted to
generate new profiles using only the allergens that individually
showed some differences in the IgE reactivity between asthmatic
and non-asthmatic individuals using the Mann-Whitney U test at a
threshold of p,0.05. This analysis generated a list of 51 relevant
allergens (Table S6) that was employed to generate new profiles
and perform clustering association analysis at k=3. The new
clusters (cluster 3, 4 and 5) revealed a striking increase in the
statistical significance of the distribution of asthma amongst the
clusters when examining the case control groups (p = 3.26E-3)
(data not shown) and the entire parent-siblings cohort (p = 3.37E-
52) as well as in the other examined atopic conditions (Table S7).
Cluster 4 showed high similarity to cluster 1 in terms of both
profile structure and composition containing a significantly high
proportion of asthmatic sera (x2 = 35.145, p = 3.06E-09) (Figure 2).
The other two clusters differed substantially from those generated
with the complete set of allergens. Cluster 5 was significantly
enriched with the reactivity profiles of most of the asthmatic
individuals not included in cluster 4 (x2 = 22.958, p= 1.65E-06),
whereas cluster 3 contained most of the non-asthmatic individuals
(x2 = 31.172, p = 2.36E-08). A very strong association could also
be observed in cluster 4 with both conjunctivitis, and rhinitis
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compared to the other clusters. Notably, the clusters generated
with the filtered set of allergens did not show a significant co-
segregation of family members (Table S8). Cluster 4 and 5
(containing nearly all the asthmatic individuals) shared some
common features in their IgE reactivity profile (Figure S1). Twenty
out of the 51 allergens (mainly inhalant) were recognized by the
sera of the two clusters but those of cluster 4 also reacted against
nine allergens mainly derived from the food and grass (allergen
19–23 and 27–30 of Table S6). Notably, cluster 4 showed a higher
proportion of individuals with diagnosis of severe asthma (severity
class 3 and 4) compared to all other clusters (Table S7) and to the
population study sample (Figure 2B).
The unusually strong association linking some IgE reactivity
profiles to asthma prompted us to generate an artificial neural
Figure 1. K-means clustering of serum reactivity profiles of 872 sera (columns) against the arrayed 103 allergens (rows). (A) The
serum reactivity profile generated for each cluster (0–2) at k=3 are visualized. Each column represents an individual serum grouped as asthmatic
(blue), non-asthmatic (gray) and undefined diagnosis (dark red). Reactivity values to individual allergens are classified as either positive (scale of red -
class score 1–5) and negative (black - class score 0). (B) The distribution of atopic conditions in each cluster was assessed using the Pearson’s X2 test.
doi:10.1371/journal.pone.0022319.g001
Table 2. Distribution of atopic traits amongst the reactivity profiles.
allergens =103* Asthma (%) Conjunctvitis (%) Eczema (%) Rhinitis (%) Sex (%)
Persistency
(%)
Severity
(%){
Age
onset{
2 + u.d1 2 + 2 + 2 + M F 2 + 1 2
Cluster 0 45.9 48.5 5.6 74.5 25.5 82.5 17.5 56.1 43.9 52.6 47.4 15.1 84.9 53.6 46.4 4.0
Cluster 1 12.2 82.6 5.2 41.8 58.2 67.6 32.4 28.1 71.9 62.8 37.2 11.1 88.9 38.5 61.5 8.5
Cluster 2 44.3 50.8 4.9 68.8 31.2 80.9 19.1 51.5 48.5 47.5 52.5 9.6 90.4 50.2 49.8 7.0
Total 39.2 55.6 5.2 65.5 34.5 79.0 21.0 48.4 51.6 51.3 48.7 10.9 89.1 47.9 52.1
x2 56.719 42.215 13.591 30.524 11.000 1.276 5.260 18.930
p-value 2.95E-12 6.81E-10 1.10E-03 2.35E-07 4.1E-03 0.528 0.072 7.75E-05
*Number of allergens utilized to generate the profiles of clusters 0–2.
{Asthma severity was classified by a physician in four levels according to the World Health Organization guidelines (Global Initiative for Asthma). For simplicity we
considered individuals being of level 1 to 2 as one group (column 1) and individuals with higher severity, level from 3 to 4, as one group (column 2).
{Median values.
1Undefined diagnosis.
doi:10.1371/journal.pone.0022319.t002
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network (ANN) classifier designed to discriminate between
asthmatic and non-asthmatic individuals on the basis of the serum
reactivity profiles. Each profile used in the supervised training
contained information concerning the reaction values for the 51
filtered allergens, and the health status of the individual with
respect to the condition of asthma. The ANN correctly classified
82% of the asthmatic patients as ‘‘asthmatic’’ and about 72% of
the non-asthmatic as ‘‘non-asthmatic’’ (Figure 3). The overall
performance of the ANN was consistent with the results obtained
by cluster analysis: the average percentage of asthmatic patients
correctly recognized by the RBF classifier as asthmatic is nearly
identical to the combined percentage of the asthmatic patients
present in clusters 4 and 5. To assess the performance of the ANN-
based approach with respect to different classification solutions, we
utilized binary logistic regression (BLR). We observed that there
was no discrepancy in classification outcome between the two
models (data not shown).
Finally, we employed a GEE model [27] to investigate whether
the presence of familiar nuclei in the study groups had introduced
a bias in the composition of the profiles or had underestimated the
standard errors of the analysis. When taking into account the
parent to sibling relationships, GEE allows the measurement of
population-averaged effects as opposed to cluster-specific effects.
We used the GEE univariate analyses to determine association
between asthma and IgE reactivity against individual allergens
(Table S9). This approach generated a list of 43 relevant allergens
with p values ,0.05 that coincided substantially with those
generated with the Mann-Whitney analysis (forty out of the 43
allergens were identical; 93.02%). To unravel association between
distinct reactivity profiles and asthma, a forward multivariate GEE
analysis was applied. In this analysis seven allergens (Table 3) were
independent predictors of asthma status, while controlling for age,
sex and the interaction between age and sex as confounding
variables. The final GEE model, factoring in the effect of parent to
sibling relationships distinguished asthmatic and non-asthmatic
individuals with high accuracy, based on their of the IgE serum
reactivity against a reduced number of relevant allergens. The
model correctly classified 88.8% of the asthmatic patients as
‘‘asthmatic’’ and 90.9% of the non-asthmatic as ‘‘non-asthmatic’’.
Six out of seven allergens are in common to the 51 relevant
allergens generated with the Mann-Whitney procedure. To assess
the performance of the GEE-based approach the reactivity profiles
against the 7 relevant allergens were utilized to perform clustering
association analysis at k=3 (Figure 4). The analysis of the new
clusters (6, 7 and 8) showed a striking increase in the statistical
significance of the distribution of asthma amongst the new clusters
(x2 = 192.549, p = 1.54E-42) (Table S10). The clusters generated
with the filtered set of 7 allergens did not show a significant co-
segregation of family members with respect to those generated
with the all set of allergens (Table S11).
Discussion
A complete understanding of the combination of allergens
differentially recognized by asthmatic and non-asthmatic individ-
Figure 2. K-means clustering of serum reactivity profiles of 827 sera (columns) against the subset of asthma relevant allergens
(rows). (A) The serum reactivity profile generated for each cluster (3–5) at k= 3 are visualized. Each column represents an individual serum grouped
as asthmatic (blue) and non-asthmatic (gray). Reactivity values to individual allergens are classified as either positive (scale of red - class score 1–5)
and negative (black - class score 0). (B) The distribution of atopic conditions in each cluster was assessed using the Pearson’s X2 test.
doi:10.1371/journal.pone.0022319.g002
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uals would be immensely beneficial for elucidating how specific
IgE contribute to the pathogenesis of the disease but progress in
this area has been slow because traditional immunoassays such as
RAST, CAP ELISA, while useful in assessing specific immune
responses, allow for the analysis of just one or few allergens at a
time. To overcome these limitations we utilized a microarray
immunoassay technology to analyze the IgE reactivity against a
vast number of natural and recombinant allergens in the sera of
asthmatic and non-asthmatic individuals. This methodology has
already been shown to be useful in the serodiagnosis of allergy,
infectious diseases, and may soon replace ELISAs in clinical
laboratory settings [25,26,27,28]. It has been widely recognized
that the analysis of the reactivity profiles not only provides a large
amount of quantitative information (the sum of the individual
reactivity), but also generates a higher order of knowledge in term
of unique combinations of antigen-antibody reactions that
associate with different experimental and pathological conditions
[26].
Using k-means clustering the serum reactivity profiles of all
individuals analyzed were arranged in three clusters that, significantly
differed from each other in terms of the combination of allergens
recognized and in the proportion of individuals affected by different
atopic diseases both amongst the case-control groups and the parent-
siblings pairs. In particular, asthmatic individuals contributed to 83%
of the reactivity profiles of cluster 1. This percentage showed a
remarkable statistical significant difference (p,10E-9) compared to
that of the asthmatic individuals in the study population. While,
cluster 0 and cluster 2 did not show significant differences in the
proportion of asthmatic and non-asthmatic individuals, the analysis of
their composition demonstrated that, in contrast to cluster 1, they
were enriched in members of the same family nuclei.We thought that
the composition of cluster 0 and 2 reflected the exposure of family
members to a common set of allergens that were included in the
microarray that though having a powerful sensitizing ability, were not
relevant for asthma and in addition could be due to cross-reactivity
[29]. Accordingly, we identified amongst the 103 arrayed allergens a
subset of 51 allergens that most differed in the IgE reactivity of
asthmatic and non-asthmatic individuals. These allergens were used
to generate new reactivity profiles that were clustered using k-means.
The new clusters showed some interesting and novel features. Cluster
4 was very similar to cluster 1 in terms of IgE recognition pattern and
the high proportion of asthmatic individuals. The two remaining
clusters also showed highly significant statistical differences in their
composition. Cluster 3 was enriched in non-asthmatic individuals
Figure 3. Architecture and performance of the RBF based ANN asthma classifier. (A) ANN architecture. The RBF network consists of three
layers: Input (boxes 1–51), hidden (circles 1–8) and output (asthma classes in blue boxes) layer respectively. (B) ANN predicted-by-observed
performance chart. The box plots represent the predicted-pseudo-probabilities for the RBF output category; non-asthmatic (green) and asthma (blue)
plotted against the known clinical status non-asthmatic (1) asthmatic (2) for combined training and testing samples. (C) The ROC curve calculated on
the combined training and testing samples. (D) ANN asthma classifier consistency performance. The ANN-predicted asthma status of the hold out
samples was assessed on a Pearson’s X2 test against the known clinical status of the selected individuals.
doi:10.1371/journal.pone.0022319.g003
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(69%) while cluster 5 contained a high percentage of asthmatic
patients (82%). The distribution of rhinitis and conjunctivitis (but not
eczema) in the clusters closely mirrored that of asthma in agreement
with other observations that have established a link amongst these
atopic diseases [30,31]. As anticipated, we did not observe in cluster
3, 4 and 5 any enrichment in members of the same family nuclei thus
indicating that the corresponding profiles are associated with the
asthma clinical status rather than to allergen exposure. The two
clusters that contained the highest proportion of asthmatic individuals
(cluster 4 and 5) reacted against the same subset of 21 allergens
though cluster 4 showed an additional specific reactivity against nine
allergens mainly of food and grasses origin. Notably cluster 4 but not
cluster 5 showed an association with asthma severity thus unraveling
an unsuspected link between disease severity, on one side and the
complexity and the specificity of the IgE response on the other one.
This result is consistent with the notion that quantification of IgE
antibodies may serve as a marker of severity of asthma [32] and that
not only IgE antibodies levels but also the number of allergens
reacting positively when tested are needed for the correct
classification of disease [33]. GEE statistical analysis showed that
the presence of family relationships amongst the individuals enrolled
in this study did not account neither for an unequal partitioning nor
for an underestimation of standard errors. The GEE multivariate
analysis could distinguish asthmatic and non-asthmatic individuals
with high accuracy, based on their of the IgE serum reactivity. In this
analysis seven allergens were independent predictors of asthma status.
Association studies performed on clusters using 7 relevant allergens
revealed that the GEE-based approach and the k-means analysis
based on the Mann-Whitney selection of allergens gave the same
results.
Table 3. Results of multivariate GEE analysis.
Variables Coefficient S.E. Wald x2 df p OR (95% CI)*
Penicillin G 0.000{
C1 - score 4 1.705 0.456 13.967 1 0.000 5.503 (2.25–13.46)
C1 - score 3 21.143 0.335 11.658 1 0.001 0.319 (0.16–0.61)
C1 - score 2 20.373 0.175 4.559 1 0.033 0.688 (0.49–0.97)
C1 - score 1 20.451 0.178 6.444 1 0.011 0.637 (0.45–0.90)
Derm. Farinae 0.000{
D2 - score 4 1.460 0.275 28.134 1 0.000 4.305 (2.51–7.38)
D2 - score 3 1.407 0.306 21.088 1 0.000 4.084 (2.24–7.45)
D2 - score 2 0.640 0.200 10.185 1 0.001 1.896 (1.28–2.81)
D2 - score 1 20.013 0.218 0.004 1 0.951 0.987 (0.64–1.51)
Kiwi 0.000{
F84 - score 4 22.207 0.541 16.619 1 0.000 0.110 (0.04–0.31)
F84 - score 3 0.130 0.299 0.189 1 0.664 1.139 (0.63–2.05)
F84 - score 2 0.484 0.207 5.462 1 0.019 1.623 (1.08–2.43)
F84 - score 1 0.469 0.210 4.985 1 0.026 1.599 (1.06–2.41)
Timothy grass 0.000{
G6 - score 4 0.912 0.493 3.413 1 0.065 2.489 (0.95–6.55)
G6 - score 3 0.865 0.310 7.795 1 0.005 2.375 (1.29–4.36)
G6 - score 2 0.604 0.190 10.094 1 0.001 1.829 (1.26–2.65)
G6 - score 1 0.949 0.233 16.628 1 0.000 2.584 (1.63–4.08)
Alpha amylase 0.011{
K87 - score 3 20.808 0.437 3.418 1 0.065 0.446 (0.19–1.05)
K87 - score 2 20.191 0.226 0.717 1 0.397 0.826 (0.53–1.29)
K87 - score 1 0.458 0.225 4.153 1 0.042 1.581 (1.02–2.46)
Ph1 p1 0.000{
X903 - score 4 2.171 0.513 17.880 1 0.000 8.765 (3.20–23.97)
X903 - score 3 0.723 0.244 8.793 1 0.003 2.060 (1.28–3.32)
X903 - score 2 0.328 0.185 3.140 1 0.076 1.388 (0.97–1.99)
X903 - score 1 0.064 0.224 0.081 1 0.776 1.066 (0.69–1.65)
Derp 1 0.038{
X904 - score 4 20.401 0.468 0.733 1 0.392 0.670 (0.27–1.68)
X904 - score 3 0.330 0.253 1.704 1 0.192 1.391 (0.85–2.28)
X904 - score 2 0.208 0.226 0.846 1 0.358 1.231 (0.79–1.92)
X904 - score 1 0.530 0.217 5.984 1 0.003 1.699 (1.11–2.60)
*Odds ratio, confidence intervals and statistical significance were calculated for each class score (4,3,2,1 with respect to class score 0) of specific IgE.
{p values for global effect test.
doi:10.1371/journal.pone.0022319.t003
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Among the 7 relevant allergens are Dermatophagoides Farinae
and Derp1 allergens, this result is not surprising, considering the
prevalence rate of both skin prick test (SPT) to Dermatophagoides
Pteronissinus and Farinae versus the other SPTs observed among
Sardinian people, respectively 82.7% and 76.9% (data not shown).
Timothy grass is a highly prevalent grass worldwide and the
prevalence of allergen-specific IgE resulted 8.1–34.6% in the
European Community Respiratory Health Survey [34]. Recent
studies showed the efficacy of timothy grass allergy immunother-
apy tablet treatment in improvement in asthma symptoms both in
North American adults and children [35,36].
The last two relevant allergens included the alpha amylase and
the kiwi. The alpha amylase is generally associated with Bakers’
asthma, the most common occupational respiratory disease,
caused by occupational exposure to the antigens from flour.
Interestingly, a potential association between respiratory allergy to
cereal flour and allergy to kiwi fruit has been recently disclosed.
Cross-reactive carbohydrate determinants and thiol-proteases
homologous to Act d1 (cysteine protease) are responsible for
wheat-kiwi cross-reactivity in some patients [37].
While this study demonstrates a link between specific IgE and
asthma it should be emphasised that a comprehensive under-
standing of the relationship between asthma and allergen specific
IgE would require an exhaustive analysis of reactivity profiles in
populations exposed to different set of allergens. The allergens
required for such findings would probably vary depending on both
subject’s age and geographical area. In this context a major
advantage of microarray immunoassays is that the composition of
different sets of allergens can be expanded and improved
continuously, facilitating the identification of the most appropriate
reactivity data profile for asthma diagnosis and hence favouring
preventive medicine and curative therapies both for asthma and
allergic diseases.
Our data demonstrate that associations between asthma and
IgE antibody responses to single allergens dramatically underes-
timate the underlying similarities and differences in individual
reactivity to the allergen repertoire that may be relevant for
understanding the causes, the severity and the progression of the
disease. This also explains why making associations between
antibody responses and disease is hard to identify. On the
contrary, by analyzing the IgE serum reactivity profiles against a
large set of allergens, we could demonstrate that asthmatic and
non-asthmatic individuals differ dramatically in terms of number
and class of recognised allergens. This information was utilised to
Figure 4. K-means clustering of serum reactivity profiles of 827 sera (columns) against the subset of asthma relevant allergens
(rows). (A) The serum reactivity profile generated for each cluster (6–8) at k= 3 are visualized. Each column represents an individual serum grouped
as asthmatic (blue) and non-asthmatic (gray). Reactivity values to individual allergens are classified as either positive (scale of red - class score 1–5)
and negative (black - class score 0). (B) The distribution of atopic conditions in each cluster was assessed using the Pearson’s X2 test.
doi:10.1371/journal.pone.0022319.g004
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train an ANN capable of distinguishing asthmatic and non-
asthmatic individuals with high accuracy based on their IgE serum
reactivity. This work provides a new framework for understanding
the role of allergen specific IgE in the pathogenesis of asthma, thus
helping in explaining the occurrence of acute episodes in the
apparent absence of exposure to a single allergen, and will prove
invaluable in implementing preventive and therapeutic measures.
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